Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum

[1]  Sergi Ferré,et al.  Antagonistic A2a/D2 receptor interactions in the striatum as a basis for adenosine/dopamine interactions in the central nervous system , 1993 .

[2]  K. Fuxe,et al.  Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal membranes. , 1993, European journal of pharmacology.

[3]  K. Fuxe,et al.  Adenosine-dopamine interactions in the brain , 1992, Neuroscience.

[4]  K. Fuxe,et al.  Dopamine denervation leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum , 1992, Brain Research.

[5]  G. Lahoste,et al.  Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density , 1992, Synapse.

[6]  J. Shine,et al.  Molecular cloning and expression of an adenosine A2b receptor from human brain. , 1992, Biochemical and biophysical research communications.

[7]  G. Stiles,et al.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. M. Adler,et al.  Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. , 1992, Brain research. Molecular brain research.

[9]  J. Palacios,et al.  Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with disease , 1991, Neuroscience.

[10]  K. Fuxe,et al.  Stimulation of adenosine A2 receptors induces catalepsy , 1991, Neuroscience Letters.

[11]  M. Parmentier,et al.  Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor. , 1991, Genomics.

[12]  S. Schiffmann,et al.  Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study , 1991, Journal of neurochemistry.

[13]  B B Fredholm,et al.  Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  U. Ungerstedt,et al.  Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice. , 1991, European journal of pharmacology.

[15]  U. Ungerstedt,et al.  Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice. , 1991, European journal of pharmacology.

[16]  S Schiffmann,et al.  RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. , 1990, Biochemical and biophysical research communications.

[17]  B. Fredholm,et al.  Autoradiographic evidence for G-protein coupled A2-receptors in rat neostriatum using [3H]-CGS 21680 as a ligand , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  T. Dunwiddie,et al.  Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. , 1990, The Journal of pharmacology and experimental therapeutics.

[19]  M. Williams,et al.  [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. , 1989, The Journal of pharmacology and experimental therapeutics.

[20]  G. Ghai,et al.  CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. , 1989, Journal of Pharmacology and Experimental Therapeutics.

[21]  M. Williams,et al.  Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680. , 1989, European journal of pharmacology.

[22]  M. Savasta,et al.  Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum , 1987, Neuroscience Letters.

[23]  C. Marsden,et al.  Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat. , 1985, Biochemical pharmacology.

[24]  S O Ogren,et al.  Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. , 1985, Biochemical pharmacology.

[25]  C. Altar,et al.  Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: Plasticity of neostriatal dopamine receptors after nigrostriatal injury , 1984, Brain Research.

[26]  U. Ungerstedt,et al.  Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre , 1982, Neuroscience Letters.

[27]  R Rubio,et al.  Brain adenosine concentration during hypoxia in rats. , 1981, The American journal of physiology.

[28]  H. Winn,et al.  Brain adenosine production in rat during sustained alteration in systemic blood pressure. , 1980, The American journal of physiology.

[29]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[30]  B B Fredholm,et al.  Modulation of neurotransmission by purine nucleotides and nucleosides. , 1980, Biochemical pharmacology.

[31]  S. Snyder,et al.  Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding. , 1979, European journal of pharmacology.

[32]  S. Snyder,et al.  Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. , 1977, Science.

[33]  S. Snyder,et al.  Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. , 1977, Science.

[34]  U. Ungerstedt,et al.  Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists. , 1974, Medical biology.

[35]  U. Ungerstedt,et al.  Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[36]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[37]  H. Klawans,et al.  An experimental model of tardive dyskinesia , 2005, Journal of Neural Transmission.

[38]  U. Ungerstedt,et al.  Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses , 2004, Psychopharmacology.

[39]  M. Caron,et al.  Recent advances in the molecular biology of dopamine receptors. , 1993, Annual review of neuroscience.

[40]  A. Tucker,et al.  Molecular cloning of adenosine A1 and A2 receptors. , 1991, Trends in pharmacological sciences.

[41]  B. Fredholm,et al.  Formation and Actions of Adenosine in the Rat Hippocampus, with Special Reference to the Interactions with Classical Transmitters , 1988 .

[42]  T. Dunwiddie.  The physiological role of adenosine in the central nervous system. , 1985, International review of neurobiology.

[43]  S. Snyder,et al.  Adenosine as a neuromodulator. , 1985, Annual review of neuroscience.

[44]  K. Fuxe,et al.  BEHAVIOURAL EFFECTS OF ERGOT DRUGS , 1979 .